Halloween is over and assorted monster costumes have been put away – but there is still monster growth to be had in certain stocks! Today’s article highlights three stocks “with strong monster growth narratives” – each of which has recently reported impressive earnings numbers and had their price targets increased by some of Wall Street’s top-performing analysts as a result. For these three “monster growth” stocks – all of which have “Strong Buy” consensus ratings and upside potential above 20% – CLICK HERE.
Each member of the popular and closely-watched FAANG stocks, as well as Microsoft, reported their most recent quarterly earnings in October – and the gains that followed some solid earnings figures helped propel the S&P 500 to an all-time high. For how each of the FAANG stocks (and Microsoft) performed in quarterly earnings, as well as how much each stock has gained so far this year, CLICK HERE.
The constituents of this S&P 500-beating index, which tracks companies that possess wide economic moats and that are trading at the lowest current market price to fair value, “are a fertile hunting ground for investors looking for high-quality stocks trading at reasonable prices,” advises the author of today’s article. As the index in question is reconstituted regularly, she proceeds to delve into the 15 newest additions to its ranks – as well as the 15 names that were recently removed from the index. For more, CLICK HERE.
The U.S. and China have reached a limited trade deal that will see the Trump Administration suspend a tariff hike on $250 billion worth of Chinese imports and China buy $40 billion to $50 billion in U.S. farm products. With this de-escalation in the protracted trade war, as well as other recent developments such as aggressive pro-stimulus measures announced by various central banks, is it safe for investors to add risk back into their portfolios? For more, CLICK HERE.
You’ve identified and bought a stock that you believe is undervalued. Now, the critical question becomes how long do you wait for that undervalued stock to recover to fair value and reward you? Noting that “the unfortunate truth is that the required timeframe often can or will try the investor’s patience beyond what they can tolerate”, the author of today’s article attempts to establish some expectations – and offers several examples illustrating how undervalued stocks can still reward investors even before recovering to fair value. For more, CLICK HERE.
The company behind WeWork is expected to go public later this year, possibly as soon as the next few weeks, and, as the author of today’s article observes, “Investors predict it will change the world as we know it—or be a money-losing disaster—seemingly with little middle ground. And it indeed has the perfect ingredients for debate: A sky-high valuation, a lack of profits, impressive growth, and an unconventional, effusive founder.” So what’s the most bullish case for WeWork – and the most bearish case? CLICK HERE.
Oil – and energy stocks – tumbled in the wake of escalating trade tensions between the U.S. and China – and the fundamental outlook for crude may not provide much reason for optimism, with one analyst cited in today’s article declaring that, with all things pointing to oversupply in the market, “I think there’s really nothing I can look at except maybe a calamity in the Persian Gulf that would drive oil up.” Against this backdrop, one market expert is “suggesting an unconventional way to play the oil and energy space.” For more, CLICK HERE.
A “rare phenomenon brewing in the stock market right now” may be setting up a “once in a decade” opportunity, according to a JPMorgan quantitative strategist. More specifically, this opportunity stems from the record level of divergence between stock groups (value/cyclical stocks and low volatility/defensive stocks) – a level that the analysts declares “is much more significant even when compared to the dot-com bubble valuations of late ’90s.” For more, CLICK HERE.
While everything appears to be falling into place for the North American marijuana industry to be an unprecedented growth opportunity, today’s article notes that, when it comes to individual cannabis companies, “Over the past seven months, three marijuana stocks have gone from having the full support of their shareholders to having partially or completely destroyed that faith in management.” For these three pot stocks that have gone from popping with promise to problem-plagued – including the firm the author singles out as “the train wreck of all train wrecks” – CLICK HERE.
Despite the market’s recent drop brought on by concerns over escalating trade tensions between the U.S. and China, it is hard for investors to find value plays amongst stocks. There is, however, still value to be had – and today’s article highlights three undervalued stocks to consider. Among them is a mid-cap stock carving out a niche in what the author notes “is the fastest-growing space within the pharmaceutical industry”: oncology. For more on these three value stocks, CLICK HERE.